Amesite Inc. Form 8-K Summary
Business Context and Reporting Period
This Current Report on Form 8-K was filed by Amesite Inc. (AMST) on February 21, 2023. The filing reports on corporate actions taken following a special meeting of stockholders held on February 15, 2023. The company is incorporated in Delaware and its common stock trades on The Nasdaq Stock Market LLC.
Key Financial Metrics
This filing does not contain financial performance data such as revenue, profit, cash flow, margins, debt, or liquidity metrics. The report focuses exclusively on corporate governance and capital structure adjustments.
Material Changes
- Reverse Stock Split: The Board of Directors approved a 1-for-12 reverse stock split of the company's outstanding common stock. This action became effective at 4:01 p.m. Eastern Time on February 21, 2023. Trading on a split-adjusted basis was expected to commence on February 22, 2023.
- Equity Plan Amendment: Stockholders approved an amendment to the 2018 Equity Incentive Plan, increasing the number of shares available for issuance by 3,000,000 shares and increasing the amount of shares issuable pursuant to incentive stock options by 3,000,000 shares.
- Security Identification: While the trading symbol remains "AMST," the security has been assigned a new CUSIP number (031094204).
Outlook, Risks, and Unusual Items
The filing details the mechanics of the reverse stock split, noting that fractional shares will be rounded up to the next whole share. Proportionate adjustments will be made to the exercise prices and share counts for all outstanding stock options, restricted stock units, and warrants. The filing does not provide specific forward-looking guidance, risk factors, or commentary on unusual items beyond the execution of these corporate actions.
Investor Verification Checklist
- Verify the new CUSIP number (031094204) for the AMST security.
- Confirm the effective date and time of the 1-for-12 reverse stock split (February 21, 2023, 4:01 p.m. ET).
- Review the impact of the reverse split on outstanding equity awards (options, RSUs, warrants) regarding adjusted exercise prices and share quantities.
- Check the definitive proxy statement (Schedule 14A filed January 23, 2023) for full details on the amended 2018 Equity Incentive Plan.